42
Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director Sarah Puddicombe, Assistant Director Chloe Gilbert, Senior Programme Manager 16/11/2015

Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

Embed Size (px)

Citation preview

Page 1: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

Evaluation, Trials and Studies Coordinating Centre

An Introduction to the NIHR Evaluations,Trials and Studies funding

Phil Taverner, Assistant Director

Sarah Puddicombe, Assistant Director

Chloe Gilbert, Senior Programme Manager

16/11/2015

Page 2: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Overview

• NIHR Strategy• Which NETS programme• What makes a good application

Page 3: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

NIHR’s Strategic Aim

To improve the health and wealth of the nation through research

Page 4: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

NIHR’s Strategic Vision

• To create a health research system in which the NHS supports:• outstanding individuals• working in world-class facilities• conducting leading-edge research• focused on the needs of patients and the

public

Page 5: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

NIHR Infrastructure

Page 6: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Added Value in Research

Page 7: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

NIHR Evaluation, Trials and Studies (NETS) programmes

NETSCC: Established: 2008

Public Health Research

Established: 2008

Health Technology Assessment

Established: 1993

Health Services and Delivery Research

Established: 2012

Efficacy and Mechanism EvaluationResearcher-ledFunded by the MRCManaged by NIHRCommissionedFunded and managed by NIHREstablished: 2008 & 2011

Page 8: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Which NETS programme?

EME – exploratory trials, less pragmatic, phase 2-3, efficacy, mechanisms if possible

HTA – systematic reviews, large multicentre pragmatic trials or other studies (phase 3-4), effectiveness in the NHS

HS&DR – organisational, patient experience, qualitative or other

PHR – effectiveness and cost effectiveness of non-NHS interventions to improve public health

Page 9: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

MRC-NIHR Efficacy and Mechanism Evaluation (EME) programme

Aim:• Support excellent clinical science with an ultimate view to improving health or patient care

Dual Approach:• “Science driven” – examine the efficacy of a technology intervention (i.e. pharmaceutical,

diagnostic test, surgical or psychological therapies, or public health measures) and/or explore its mechanisms of action

EME will support clinical trials and evaluative studies in patients that;• provide definitive evidence of efficacy of healthcare interventions• add significantly to understanding of disease mechanisms• break new ground – new scientific or clinical principles• include validated surrogate markers as indicators of patient outcomes

EME will not support;• incremental modifications or refinements of existing technologies• proof of concept, proof of mechanism in humans (i.e. early phase clinical trials) or

confidence in effect studies

Page 10: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Characteristics of EME research

• Primary research only• Evaluates efficacy, safety and possibly effectiveness of an

intervention under ideal conditions• Clinical trials or evaluative studies (not necessarily RCTs), may also

include mechanistic studies which:

Are fully worked up and embedded in the main study

Are hypothesis driven with a feasible research question

Aim to advance scientific understanding of the disease mechanism or the mechanism of action of the treatment

• Small to large number of participants – may include stringent eligibility criteria

• Technologies are usually mostly developed and defined, but may require some refinement/fine tuning

• Likely to include placebo as a comparator but could be usual care or the best active alternative

Page 11: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

EME project examples

Probiotic to Reduce Infections iN CarE home Service userS (PRINCESS) – Prof Chris Butler£1.8million (39 months)(Co-applicants from Cardiff University, South East Wales Trials Unit and Public Health Wales)

Clinical Efficacy and Mechanistic Evaluation of Aflibercept for Proliferative Diabetic Retinopathy (CLARITY) - Prof Sobha Sivaprasad£1.2million (36 months) (Co-applicant, Bangor University, Rhiannon Tudor Edwards)

Molecular selection of therapy in metastatic colorectal cancer: a molecularly stratified randomised controlled trial programme (FOCUS 4) – Prof Tim Maughan£3.5million (84 months) (CARDIFF, Co-applicants, Richard Adams, Bharat Jasani, Rachel Butler)

Page 12: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

NIHR Health Technology and Assessment (HTA) programme

Purpose and Remit• To deliver high quality research information on the effectiveness, costs and broader

impact of healthcare treatments and tests for those who plan, provide or receive care in the NHS.

What is a health technology?• The term includes all interventions used to promote health, prevent or treat disease,

improve rehab or long-term care including drugs, devices, procedures, settings of care and screening.

What are health technology assessments?• Large-scale evidence syntheses• Pragmatic trials• Diagnostic evaluation studies• Short reports• Miscellaneous others

Page 13: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Characteristics of HTA Research

• Funds both primary and secondary research. For primary research:• Usually pragmatic research– evaluating effectiveness in a real-world

NHS setting• Multidisciplinary and multi-centre generating results that are

generalisable to the NHS• Generally a large number of participants, adequate to assess

minimally clinically important differences from a patient perspective. Participant eligibility criteria are wide and representative of the UK population and represent the mix of patients likely to be seen in normal clinical practice

• Usually evaluate a fully defined and developed technology, compared to the best active alternative or usual care. Placebos may be used in conjunction with best treatment to blind trial participants

• Usually include cost effectiveness or cost utility• Feasibility and pilot studies are eligible

Page 14: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

HTA Project Examples

Seal or Varnish? A randomised trial to determine the relative cost and effectiveness of pit and fissure sealants and fluoride varnish in preventing dental decay Prof Ivor Chestnutt , Cardiff University£1.3million (60 months)

ANti-psychotic Drug REduction in primary care for Adults with Learning Disabilities (ANDREA-LD): A Randomised Double-blind Placebo Controlled Trial Prof Michael Kerr, Cardiff University£1.4million (39 months)

Developing a multidisciplinary rehabilitation package following hip fracture. Acronym: Fracture in the Elderly Multidisciplinary Rehabilitation (FEMuR) Dr Nefyn Williams, Bangor University£500,000 (39months)

Page 15: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

NIHR Health Services & Delivery Research (HS&DR) Programme

Purpose and Remit

• The HS&DR programme funds research to improve the quality, effectiveness and accessibility of the NHS, including evaluations of how the NHS might improve delivery of services.

• The audience for this research is the public, service users, clinicians and managers.

Page 16: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

NIHR Health Services & Delivery Research (HS&DR) Programme

Principles

• The programme will support a range of types of research including evidence synthesis and primary research

• Keen to support a variety of ambitious evaluative research to improve health services, on topics of national importance

• Pilot and feasibility studies considered

• Projects which look at the relevant areas of social care as well as health will be considered

• No cap to funding, instead appropriate costing and value for money

Page 17: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

NIHR Health Services & Delivery Research (HS&DR) Programme

We support:• Research into any aspect of health service quality, accessibility and

effectiveness, as long as its importance to the NHS can be clearly demonstrated• Any methodology: qualitative, quantitative, mixed-methods, RCT• Studies which will generate national learning – generalisable findings, and

actionable results (multi-centre, regional, nationwide, international with useful learning and implementable outcomes)

We do not support:• Low importance• Single site/ local studies• Service developments, audits or needs assessments • Basic scientific or epidemiological research on the causes of disease• Testing of new health technologies or diagnostic techniques (HTA)• Establishment of a database, as an end in itself• PhD studentships

Page 18: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

HS&DR project examples

The transition from paediatric to adult diabetes services: what works, for whom and in what circumstances? Prof Davina Allen , Cardiff University£380,000 (49months)

Integration of social care staff within community mental health teams Prof Peter Huxley, Swansea University£200,000 (48months)

Evidence into practice: evaluating a child centred intervention for diabetes medicine management Prof Jane Noyes, Bangor University £600,000 (54months)

Page 19: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

NIHR Public Health Research (PHR) programme

• Purpose and Remit

The PHR programme evaluates public health interventions, providing new knowledge on the benefits, costs, acceptability and wider impacts of non-NHS interventions intended to improve the health of the public and reduce inequalities in health.

The scope of the programme is multi-disciplinary and broad covering a range of public health interventions.

Page 20: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

NIHR Public Health Research (PHR) programme

• Funds the evaluation of non-NHS interventions intended to improve the health of the public and reduce inequalities in health

• Unable to fund intervention costs• National programme open to researchers from across the UK• Includes qualitative and quantitative research which evaluates the

effectiveness and cost-effectiveness of public health interventions • Primary outcome measure must be health related

Page 21: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

NIHR Public Health Research (PHR) programme

What Public Health Research Adds:

Evidence for Education

• Teacher training and school environment to promote health

• Building social and emotional wellbeing

• Promoting physical activity

and healthy diet

• Preventing smoking, alcohol

and substance misuse

Page 22: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

NIHR Public Health Research (PHR) programme

What Public Health Research Adds:Evidence for Local Decisions

• Urban regeneration and health

• Community engagement and disadvantaged communities

• Alcohol environment

Page 23: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

NIHR Public Health Research (PHR) programme

• Transport – urban motorway, free bus travel, active and sustainable travel

• Housing quality and energy efficiency

• Effect of reducing street lighting on crime and

road accidents

What Public Health Research Adds:

Evidence for Environmental Health

Page 24: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

PHR project examples

Health impact, and economic value, of meeting housing quality standards Prof Ronan Lyons, Swansea University£540,000 (66months)

Change in alcohol outlet density and alcohol-related harm to population health (CHALICE): A comprehensive record-linked database study in WalesProf David Fone, Cardiff University £420,000 (34months)

Adapting and piloting the ASSIST model of informal peer-led intervention delivery to the Talk to Frank drug prevention programme in UK secondary schools (ASSIST+Frank): an exploratory trialProf James White, Cardiff University£500,000 (31months)

Page 25: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Any Questions?

Page 26: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

Evaluation, Trials and Studies Coordinating Centre

What makes a good NIHR application?

16/11/2015

Page 27: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Overview of an application process

Two stage process (outline & Full)

Advisory Panels consider importance/need (variations across NIHR)Panels/Boards consider scientific quality, feasibility, host, team andvalue for money

External peer and public review

Submission to decision:~ 3.5 months Evidence Synthesis (straight to full - one stage)~7.5 months Primary or ES( EoI/outline and full - two stage)

Funding Call

Outline application

Competitiveness & remit Check

Advisory panel/ Board assessment

Feedback and invite full proposal

External Review

Recommendations to DH

Advisory panel/ Board assessment

Full application

Page 28: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Project funding

• Full & Appropriate Funding – no upper limit on the amount of funding granted for a project.

• University based projects: up to 80% of the Full Economic Cost (FEC).

• NHS Trust based projects: 100% of the direct costs.

• Other organisations are also welcome to apply.

Page 29: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Commissioned of Researcher-led?

All programmes offer both workstreams

Commissioned

• Read the commissioning brief

• Check the supporting specification document and remit info

• Ensure your project fits – tailor if needed

Contact the programme in case of query – email in summary for remit advice

Researcher-led

• Check the remit of the programme • Search for funded projects

(website) for examples info on costs, duration, methodology, team etc

Page 30: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Choose the right question

• Has it already been answered?

• Has the funding stream funded similar research?

• Does it matter to patients?

• Will it make a difference to health?

• Will doctors and allied health professionals care enough to want to participate?

• Can it be implemented in the NHS?

Page 31: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Choose the right research method and describe it clearly and fully

• Is an RCT appropriate?– Primary outcome– Control group– Sample size/ power – Recruitment and retention– Avoiding bias

• If using a non-RCT design is it robust?• Is it worth investigating cost-effectiveness? • Would a mixed methods or qualitative study be appropriate?

• Use check lists: CONSORT, SPIRIT, EQUATOR

Page 32: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Pick your team carefully

• Seniority of PI

• Consider involving a CTU

• Comment on track record and experience of team

• Make sure enough statistical support is in place

• Include team members with expertise in specific methodologies (e.g. health economics, qualitative research) and experience (trials, commissioning)

• PPI• Be careful of having too many ‘chiefs’!

Page 33: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Make sure the proposal is feasible

• Design

• Context

• Timing

• Provide evidence of feasibility

• If unclear consider a feasibility study (with pre-defined feasibility criteria)

• Recruitment rate: Study sites, eligible patients, patient consents, follow-up, adequate retention of participants, expectations of service providers/patients – consider contingency arrangements

• Leave enough time for study set up, including ethics and research governance approvals and include the costs for this phase

Page 34: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Think about who you are writing for

• Simple English for mixed audience– Clinical, methodologists, reviewer, panel /board– Patient and public– Tell the story well for the non-expert– Follow the writing guides/ Newspaper style

• Clear plain English summary- Understandable to any member of the public or

panel

• Visible headings – (e.g. sample size, outcomes, technologies)

• Create white space – use paragraphs• Flow diagrams• PROOF-READ SUBMISSIONS CAREFULLY!

Page 35: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Produce a carefully costed proposal

• Sorting out the budget takes time!• Is cost to address the health issue justified ?• Does the topic account for costs requested and provide value for

money - be realistic in costing • Cost at plausible % FTE rates• Full applications are scrutinised by NIHR accountants who will check

and challenge• For many funding streams total costs should be identified at the

outline stage with limited wiggle room at the full stage• Account appropriately for research costs, NHS treatment costs and

NHS support costs

Page 36: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Include public and patents (and pay them)

Public and Patient involvement (PPI) matters to the NIHR

- consider it carefully and justify your decisions

Questions from the application form:• Were patients and the public actively involved in identifying the research topic or

prioritising the research questions? If not why not?• Were patients and the public actively involved in preparing this application?• If yes to either or both of these questions, please give details. Describe how patient and

public involvement has informed and/or influenced the development of the application and how patients and the public have been involved.

• If no to either or both questions, please explain why patient and public involvement was not thought necessary.

• Please indicate the ways in which patients and the public will be actively involved in the proposed research.

• If active involvement is planned, please give more details, including how it will benefit the research, the reasons for taking this approach and arrangements for training and support.

• If there are no plans for active involvement, please explain why it is not thought necessary

Page 37: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Have an imaginative plan for dissemination

• Think about who the main stakeholders are for your research and how learning can be shared rapidly and effectively with them– Commissioners– Providers– Health care professionals– Patients

• Consider working with stakeholders to develop your dissemination plan

• Be creative and plan to target all audiences (not just publications - movie, website, social media )

Page 38: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Feedback from funding boards

• Feedback from funding boards at all stages is meant to be helpful to the applicants

• Applicants should respond to all areas highlighted as necessary by the funding board

Page 39: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Tips for success

• Read the detailed brief , call guidance notes & FAQs http://www.nihr.ac.uk/funding/applying-for-funding.htm

• Check application fits within the programme remit www.nets.nihr.ac.uk/faqs/remit

• Check the existing portfolio of research http://www.nihr.ac.uk/research/programme-studies.htm and UKCRN portfolio: http://public.ukcrn.org.uk/search/

• Demonstrated PPI and good quality plain language summary

• Proof read application

• Don’t leave it to the last minute !

Page 40: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Get help

• CTUs, RDS, research networks

• Patient groups & INVOLVE

• Appropriate methodologists/Statisticians

• Web resources – Guidance notes, tips for success in applying

http://www.nets.nihr.ac.uk/funding

• Contact us – we’re friendly and helpful

Page 41: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Any Questions?

Page 42: Evaluation, Trials and Studies Coordinating Centre An Introduction to the NIHR Evaluations,Trials and Studies funding Phil Taverner, Assistant Director

www.nihr.ac.uk

Where can I find help?

• For more information, visit:

http://www.nets.nihr.ac.uk/programmes

• Enquiries welcome:

http://www.nets.nihr.ac.uk/contact

• Adding Value in Research:

http://www.nets.nihr.ac.uk/about/adding-value-in-research

• Webinars